NCT03334981View on ClinicalTrials.gov

Interest of Concentrations in Meconium of Buprenorphine and Methadone as a Prognostic Factor of NAS Outcome

CompletedOBSERVATIONAL
Enrollment

92

Participants

Timeline

Start Date

July 31, 2012

Primary Completion Date

July 31, 2014

Study Completion Date

July 31, 2015

Conditions
Neonatal Abstinence Syndrome
Interventions
PROCEDURE

Concentrations in Meconium of Buprenorphine and Methadone

buprenorphine or methadone concentration measurement

Trial Locations (1)

Unknown

Caen University Hospital, Caen

All Listed Sponsors
lead

University Hospital, Caen

OTHER

NCT03334981 - Interest of Concentrations in Meconium of Buprenorphine and Methadone as a Prognostic Factor of NAS Outcome | Biotech Hunter | Biotech Hunter